chr10-51697364-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_015235.3(CSTF2T):c.*335C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.333 in 222,910 control chromosomes in the GnomAD database, including 16,251 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.37 ( 13474 hom., cov: 32)
Exomes 𝑓: 0.26 ( 2777 hom. )
Consequence
CSTF2T
NM_015235.3 3_prime_UTR
NM_015235.3 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.00600
Genes affected
CSTF2T (HGNC:17086): (cleavage stimulation factor subunit 2 tau variant) Enables RNA binding activity. Predicted to be involved in pre-mRNA cleavage required for polyadenylation. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
PRKG1 (HGNC:9414): (protein kinase cGMP-dependent 1) Mammals have three different isoforms of cyclic GMP-dependent protein kinase (Ialpha, Ibeta, and II). These PRKG isoforms act as key mediators of the nitric oxide/cGMP signaling pathway and are important components of many signal transduction processes in diverse cell types. This PRKG1 gene on human chromosome 10 encodes the soluble Ialpha and Ibeta isoforms of PRKG by alternative transcript splicing. A separate gene on human chromosome 4, PRKG2, encodes the membrane-bound PRKG isoform II. The PRKG1 proteins play a central role in regulating cardiovascular and neuronal functions in addition to relaxing smooth muscle tone, preventing platelet aggregation, and modulating cell growth. This gene is most strongly expressed in all types of smooth muscle, platelets, cerebellar Purkinje cells, hippocampal neurons, and the lateral amygdala. Isoforms Ialpha and Ibeta have identical cGMP-binding and catalytic domains but differ in their leucine/isoleucine zipper and autoinhibitory sequences and therefore differ in their dimerization substrates and kinase enzyme activity. [provided by RefSeq, Sep 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.686 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.368 AC: 55894AN: 151786Hom.: 13422 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
55894
AN:
151786
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.256 AC: 18187AN: 71006Hom.: 2777 Cov.: 0 AF XY: 0.257 AC XY: 9442AN XY: 36736 show subpopulations
GnomAD4 exome
AF:
AC:
18187
AN:
71006
Hom.:
Cov.:
0
AF XY:
AC XY:
9442
AN XY:
36736
Gnomad4 AFR exome
AF:
AC:
1521
AN:
2174
Gnomad4 AMR exome
AF:
AC:
1211
AN:
3724
Gnomad4 ASJ exome
AF:
AC:
535
AN:
2510
Gnomad4 EAS exome
AF:
AC:
1664
AN:
4278
Gnomad4 SAS exome
AF:
AC:
1217
AN:
4188
Gnomad4 FIN exome
AF:
AC:
682
AN:
2930
Gnomad4 NFE exome
AF:
AC:
9968
AN:
46218
Gnomad4 Remaining exome
AF:
AC:
1303
AN:
4628
Heterozygous variant carriers
0
641
1282
1924
2565
3206
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
124
248
372
496
620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.369 AC: 56015AN: 151904Hom.: 13474 Cov.: 32 AF XY: 0.366 AC XY: 27148AN XY: 74218 show subpopulations
GnomAD4 genome
AF:
AC:
56015
AN:
151904
Hom.:
Cov.:
32
AF XY:
AC XY:
27148
AN XY:
74218
Gnomad4 AFR
AF:
AC:
0.692558
AN:
0.692558
Gnomad4 AMR
AF:
AC:
0.319253
AN:
0.319253
Gnomad4 ASJ
AF:
AC:
0.2203
AN:
0.2203
Gnomad4 EAS
AF:
AC:
0.354094
AN:
0.354094
Gnomad4 SAS
AF:
AC:
0.294606
AN:
0.294606
Gnomad4 FIN
AF:
AC:
0.24005
AN:
0.24005
Gnomad4 NFE
AF:
AC:
0.219886
AN:
0.219886
Gnomad4 OTH
AF:
AC:
0.327488
AN:
0.327488
Heterozygous variant carriers
0
1522
3044
4566
6088
7610
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
508
1016
1524
2032
2540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1195
AN:
3468
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at